Symposier - Acute Respiratory Distress Syndrome

Links shared publicly online about this topic.

  • 1,145
    total visits

Symposier - Acute Respiratory Distress Syndrome

symposier.com

Uploaded and Shared in Youtube by: ed4nurses Part of the Pulmonary Emergencies program, a short video on ARDS from David W. Woodruff, MSN, RN-BC, CNS, CEN and http://www.Ed4Nurses.com.

View full resource at symposier.com

Tags: Emergency, Nervous System, ARDS, Respiratory Distress Syndrome, Disease and Condition, Pulmonology

  • Share

Most Recently Shared on March 17, 2012 at 3:48 pm By:

Surfaxin receives FDA approval for prevention of RDS in premature infants

news-medical.net — “The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 27, 2012 at 1:12 pm By:

NewsMedical News-Medical.Net Health News

Surfaxin receives FDA approval for prevention of RDS in premature infants: The U.S. Food and Drug Administration... http://t.co/gUtgTOgn

3 weeks ago...

Cesarean delivery doesn’t protect small preemies — OBG Management

obgmanagement.com — “Cesarean delivery doesn’t protect small preemies — OBG ManagementView full resource at obgmanagement.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 12:21 pm By:

jsequoia Jacqueline Sequoia, MD MPH Surgeon, Physician, Doctor, and ObGyn Physician

#Cesarean delivery increases the risk of respiratory distress syndrome for preterm small-for-gestational-age #newborns http://t.co/9nYTIBIC

4 weeks ago...

New FDA approved drug to treat infants with respiratory distress syndrome

news-medical.net — “Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 7, 2012 at 6:35 pm By:

Arthritis_News News-Medical.Net Health News

Arthritis News: New FDA approved drug to treat infants with respiratory distress syndrome: Scientific advances a... http://t.co/YLuUBhjg

1 month ago...

FDA approves Surfaxin to prevent breathing disorder in premature infants

fda.gov — “The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on March 6, 2012 at 9:35 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

#FDA approves Surfaxin to prevent breathing disorder in premature infants http://t.co/dusHw88V

1 month ago...

Unable to connect to database server

sciencecodex.com — “Unable to connect to database serverView full resource at sciencecodex.com

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 12:50 pm By:

sarasteinmd Sara Stein MD Physician, Doctor, and Psychiatrist

Wow! Using a growth hormone agonist may prevent the respiratory distress syndrome that occurs with pneumonia when... http://t.co/rctm0SlX

2 months ago...

Vaginal progesterone safe and effective in preventing preterm birth

news-medical.net — “Women with a short cervix should be treated with vaginal progesterone to prevent preterm birth, according to a landmark study by leading obstetricians around the world. Vaginal progesterone decreased the rate of preterm birth by 42%, and significantly reduced the rate of respiratory distress syndrome and the need for mechanical ventilation, as well as a composite of several complications of premature newborns.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 15, 2011 at 9:25 am By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Vaginal progesterone safe and effective in preventing preterm birth: Women with a short cervix s... http://t.co/VXU8n3qp

4 months ago...

Salk Breathes New Life Into Fight Against Primary Killer Of Premature Infants

medicalnewstoday.com — “A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 19, 2011 at 10:05 am By:

mnt_asthma MNT Asthma News Health News

Salk Breathes New Life Into Fight Against Primary Killer Of Premature Infants http://t.co/gczBVzFl #asthma

6 months ago...

Maternal Diabetes May Not Affect Outcomes in Preterm Infants - QualityPoint Technologies

qualitypointtech.net — “Pregestational or gestational diabetes with good follow-up does not seem to be a significant risk factor of respiratory distress syndrome or other major complications in very-low-birth-weight infants. Medscape Medical NewsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 10:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Maternal Diabetes May Not Affect Outcomes in Preterm Infants: Pregestational or gestational diabetes with good fol... http://t.co/IlJLyePK

7 months ago...

Emergency Medicine Article | Respiratory Distress Syndrome, Newborn

mdlinx.com — “Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractantView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 6:22 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or b... http://t.co/WdbNlEA #ER

7 months ago...

Discovery Labs Submits Surfaxin Complete Response to FDA

drugs.com — “Surfaxin (lucinactant) is a new drug in development for the treatment of Respiratory Distress Syndrome. Surfaxin information includes news, clinical trial results and side effects.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 3:09 am By:

Drugs_Devices Drugs and Devices OW OW Health

Discovery Labs Submits Surfaxin Complete Response to FDA: WARRINGTON, Pa., Sept. 6, 2011 /PRNewswire/ -- D... http://t.co/XEOE0rv #drug

7 months ago...

Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma

chestjournal.chestpubs.org — “Peters, Jay; Singh, Harjinder; Brooks, Edward G.; Diaz, Joseph; Kannan, Thirumalai R.; Coalson, Jacqueline J.; Baseman, Janet G.; Cagle, Marianna; Baseman, Joel B.View full resource at chestjournal.chestpubs.org

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 2:11 pm By:

JuanCIvancevich Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician

Subjects with refractory asthma may be chronically infected with Mycoplasma pneumoniae http://t.co/Lp9kMZa

8 months ago...

Neonatal respiratory distress syndrome: an inflamm... [Neonatology. 2011] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on August 4, 2011 at 4:53 pm By:

Toxin_Wisdom Toxins OW OW Health

Neonatal respiratory distress syndrome: an inflammatory disease?: Authors: Speer CP Surfactant substitution ... http://bit.ly/qZAVh3

8 months ago...

Emergency Medicine Article | Respiratory Distress Syndrome, Newborn

mdlinx.com — “Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 3:50 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants... http://bit.ly/ohXYWr #ER

9 months ago...

GA Society of the American College of Surgeons: The Obesity Paradox: Obese Patients Less Likely To Develop And Die From Respiratory Distress Syndromes After Surgery

gasacs.blogspot.com — “GA Society of the American College of Surgeons: The Obesity Paradox: Obese Patients Less Likely To Develop And Die From Respiratory Distress Syndromes After SurgeryView full resource at gasacs.blogspot.com

  • View Related
  • Share

Most Recently Shared on July 11, 2011 at 2:54 pm By:

GaSACS GaSACS Health Organization

The Obesity Paradox: Obese Patients Less Likely To Develop And Die From Respiratory Distress… http://goo.gl/fb/OxLQm

9 months ago...

Infectious Disease Article | Respiratory Distress Syndrome, Adult

mdlinx.com — “Super-spreaders in infectious diseasesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 11, 2011 at 2:12 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Super-spreaders in infectious diseases: International Journal of Infectious Diseases http://bit.ly/qqT56K #ID

9 months ago...

Advertisement